PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 261 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360,194 | -96.2% | 43,137 | -94.0% | 0.00% | -100.0% |
| Q2 2023 | $9,597,705 | +34.7% | 721,632 | +17.3% | 0.01% | +25.0% |
| Q1 2023 | $7,124,607 | +236.7% | 615,251 | +137.8% | 0.01% | +300.0% |
| Q4 2022 | $2,115,946 | +107.2% | 258,673 | +47.1% | 0.00% | +100.0% |
| Q3 2022 | $1,021,000 | -90.4% | 175,861 | -92.7% | 0.00% | -91.7% |
| Q2 2022 | $10,600,000 | +61.2% | 2,398,287 | +231.9% | 0.01% | +100.0% |
| Q1 2022 | $6,575,000 | -72.9% | 722,527 | -39.0% | 0.01% | -70.0% |
| Q4 2021 | $24,229,000 | -38.6% | 1,184,214 | -23.3% | 0.02% | -44.4% |
| Q3 2021 | $39,458,000 | -3.8% | 1,544,332 | +31.7% | 0.04% | 0.0% |
| Q2 2021 | $41,017,000 | +474.0% | 1,172,919 | +446.7% | 0.04% | +414.3% |
| Q1 2021 | $7,146,000 | +428.6% | 214,545 | +56.6% | 0.01% | +600.0% |
| Q3 2020 | $1,352,000 | -9.8% | 136,999 | -68.5% | 0.00% | -50.0% |
| Q2 2020 | $1,499,000 | +129.9% | 434,672 | +104.0% | 0.00% | +100.0% |
| Q1 2020 | $652,000 | -81.8% | 213,078 | -69.4% | 0.00% | -75.0% |
| Q4 2019 | $3,577,000 | +79.8% | 695,814 | +80.5% | 0.00% | +100.0% |
| Q3 2019 | $1,989,000 | +2.5% | 385,456 | +20.2% | 0.00% | 0.0% |
| Q2 2019 | $1,940,000 | -81.9% | 320,616 | -78.3% | 0.00% | -85.7% |
| Q1 2019 | $10,693,000 | -31.2% | 1,479,032 | -29.6% | 0.01% | -33.3% |
| Q4 2018 | $15,539,000 | +994.3% | 2,099,833 | +699.9% | 0.02% | +950.0% |
| Q3 2018 | $1,420,000 | +3363.4% | 262,512 | +2160.5% | 0.00% | – |
| Q2 2018 | $41,000 | +64.0% | 11,613 | -4.9% | 0.00% | – |
| Q1 2018 | $25,000 | -83.2% | 12,213 | -78.4% | 0.00% | – |
| Q4 2017 | $149,000 | -77.3% | 56,468 | -54.9% | 0.00% | -100.0% |
| Q3 2017 | $657,000 | +701.2% | 125,240 | +444.0% | 0.00% | – |
| Q2 2017 | $82,000 | -24.1% | 23,022 | -18.9% | 0.00% | – |
| Q4 2016 | $108,000 | -91.5% | 28,372 | -80.0% | 0.00% | -100.0% |
| Q3 2016 | $1,269,000 | -16.8% | 141,568 | -34.7% | 0.00% | -33.3% |
| Q2 2016 | $1,526,000 | +49.0% | 216,884 | +178.1% | 0.00% | +50.0% |
| Q4 2015 | $1,024,000 | +59.8% | 77,997 | -55.4% | 0.00% | +100.0% |
| Q3 2015 | $641,000 | -48.2% | 174,942 | -18.7% | 0.00% | -50.0% |
| Q2 2015 | $1,238,000 | -40.0% | 215,062 | -39.1% | 0.00% | -33.3% |
| Q1 2015 | $2,063,000 | -63.0% | 353,144 | -50.3% | 0.00% | -57.1% |
| Q4 2014 | $5,574,000 | +424.4% | 710,941 | +228.2% | 0.01% | +600.0% |
| Q3 2014 | $1,063,000 | +269.1% | 216,607 | +364.6% | 0.00% | – |
| Q2 2014 | $288,000 | -4.3% | 46,623 | -17.1% | 0.00% | – |
| Q1 2014 | $301,000 | +42.7% | 56,209 | +39.6% | 0.00% | – |
| Q4 2013 | $211,000 | -56.7% | 40,269 | -54.3% | 0.00% | -100.0% |
| Q3 2013 | $487,000 | +268.9% | 88,023 | +67.6% | 0.00% | – |
| Q2 2013 | $132,000 | – | 52,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |